3,4-Dihydroxyphenylacetic acid

3,4-Dihydroxyphenylacetic acid (also known as DOPAC) is a metabolite of the neurotransmitter dopamine. It is created by the action of the enzyme monoamine oxidase (MAO) on dopamine. DOPAC is then typically converted into homovanillic acid (HVA) by the action of the enzyme catechol-O-methyl transferase (COMT).

Metabolism[edit | edit source]

DOPAC is a major metabolite of dopamine, which is a crucial neurotransmitter in the central nervous system. The metabolism of dopamine into DOPAC is a two-step process. First, dopamine is oxidized by the enzyme monoamine oxidase to produce DOPAC. This reaction also produces hydrogen peroxide (H2O2), which can be harmful to cells if not properly managed. The second step is the methylation of DOPAC by the enzyme catechol-O-methyl transferase to produce homovanillic acid.

Role in Disease[edit | edit source]

Alterations in the levels of DOPAC and other dopamine metabolites have been implicated in a number of neurological disorders, including Parkinson's disease, schizophrenia, and mood disorders. For example, patients with Parkinson's disease often have lower levels of DOPAC in their cerebrospinal fluid, which may reflect a decrease in dopamine production.

Measurement[edit | edit source]

The levels of DOPAC and other dopamine metabolites can be measured in various body fluids, including blood, urine, and cerebrospinal fluid. This can be useful for diagnosing and monitoring the progression of diseases that affect dopamine metabolism.

See Also[edit | edit source]

3,4-Dihydroxyphenylacetic acid Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.